Cue Biopharma Inc CUE

US Biotechnology

$31.41 ▼ -4.38% ($-1.44)

🎈 Low Float 🎢 High Beta

Open $33.12

Prev Close $32.85

Day Range $30.75 – $33.40

52W Range $4.97 – $45.50

Market Cap $228.18M

Beta 2.81

EPS (TTM) $-26.99

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2018-01-02
Shares Out.	4,050,000
Website	cuebiopharma.com/ ↗
Phone	13026587581
Employees	29
Revenue	$7.9M
Gross Profit	$7.9M
Net Income	-$153.1M
Free Cash Flow	-$50.2M
Total Assets	$30.7M
Total Liabilities	$28.4M
Equity	$2.3M

About Cue Biopharma Inc

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

Cue Biopharma Inc is a publicly traded company under the ticker symbol CUE on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.